Published in Prostate on February 15, 1999
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. Cancer Discov (2012) 1.87
Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer. Cancer Discov (2012) 0.89
Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm. Eur Radiol (2015) 0.82
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution. Nucl Med Biol (2014) 0.77
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry (1990) 2.07
Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer (1984) 1.80
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol (2007) 1.55
Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A (1983) 1.46
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
Focus on abdominal rectopexy for full-thickness rectal prolapse: meta-analysis of literature. Tech Coloproctol (2011) 1.43
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology. Cancer (1979) 1.37
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer (1986) 1.13
An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry (1991) 1.10
Coumarins from Ferulago capillaris and F. brachyloba. Phytochemistry (2000) 1.09
The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol (1982) 1.07
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology (1997) 1.03
Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology. Anal Cell Pathol (1998) 1.01
Flow cytofluorometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol (1982) 1.01
Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy (2002) 1.00
Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum (1991) 1.00
p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol (1994) 0.99
Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res (1999) 0.98
Total gastrectomy in the treatment of adenocarcinoma of the cardia. Review of the results in 73 resected patients. Am J Surg (1986) 0.95
Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem (1996) 0.95
S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer (1996) 0.94
Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry (1993) 0.93
An unusual case of small intestine evisceration through a transverse loop colostomy. Colorectal Dis (2012) 0.93
Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut (1987) 0.93
Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res (1989) 0.93
Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol (2000) 0.93
Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother (1984) 0.93
Investigation on cell proliferation with a new antibody against thymidine kinase 1. Anal Cell Pathol (2001) 0.92
Lol p XI, a new major grass pollen allergen, is a member of a family of soybean trypsin inhibitor-related proteins. J Allergy Clin Immunol (1995) 0.91
DNA ploidy and cell phase in human pituitary tumors. Cancer (1984) 0.91
Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol (1996) 0.91
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene (1994) 0.91
DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum (1994) 0.91
DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res (1982) 0.90
Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism. Eur J Vasc Endovasc Surg (2001) 0.90
Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J Urol (1992) 0.89
Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol (2006) 0.88
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol (1996) 0.88
Flow-cytometric DNA analysis as a means for early detection of malignancy in patients with chronic ulcerative colitis. Gut (1984) 0.88
DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology (1992) 0.88
DNA microspectrophotometry of bone sarcomas in tissue sections as compared to imprint and flow DNA analysis. Cytometry (1986) 0.87
Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings. Urol Res (1978) 0.87
Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl (1994) 0.87
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells. Exp Cell Res (1987) 0.86
Laparoscopic adrenal surgery: new frontiers. J Endourol (2005) 0.86
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Clin Cancer Res (2000) 0.86
Quantitative analysis of antiviral drug toxicity in proliferating cells. Cell Biol Toxicol (1986) 0.86
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma. Br J Cancer (1999) 0.86
Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy. Anal Quant Cytol Histol (1992) 0.85
New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci (2011) 0.85
The loss of ions from Venus through the plasma wake. Nature (2007) 0.85
Comparative single cell and flow DNA analysis in aspiration biopsies from breast carcinomas. Acta Pathol Microbiol Scand A (1980) 0.85
DNA measurements of human pituitary tumours. Acta Otolaryngol Suppl (1981) 0.84
Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study. Cancer (1984) 0.84
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients. Br J Cancer (1999) 0.84
Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol (1984) 0.84
The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. J Urol (1990) 0.84
Analysis of cell flow and cell loss following X-irradiation using sequential investigation of the total number of cells in the various parts of the cell cycle. Cell Tissue Kinet (1985) 0.84
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of thymidine on wild-type and dCMP deaminase-deficient mouse S49 T-lymphoma cells. Exp Cell Res (1984) 0.84
Hydroxyurea-induced cell death as related to cell cycle in mouse and human T-lymphoma cells. Cancer Res (1987) 0.84
Characterization of bladder carcinomas by flow DNA analysis. Eur Urol (1985) 0.83
Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif (1991) 0.83
DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop Scand (1991) 0.83
DNA flow analysis of soft tissue tumors. Cancer (1987) 0.83
Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Int J Cancer (1983) 0.83
Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research. Prostate (1997) 0.83
Extracorporeal shock wave lithotripsy in an elderly population: how to prevent complications and make the treatment safe and effective. J Endourol (2008) 0.83
Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Anticancer Res (1994) 0.83
Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells. Exp Cell Res (1982) 0.83
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry (1993) 0.83
Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by the two methods. Cytometry (1986) 0.83
p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res (1994) 0.83
DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol (1982) 0.83
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency. Amyloid (2011) 0.82
Laparoscopic telementored adrenalectomy: the Italian experience. Surg Endosc (2005) 0.82
Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression. Anticancer Res (1996) 0.82
Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 0.82
Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood (1995) 0.82
Comparative single-cell and flow DNA analysis of bone sarcoma. Anal Quant Cytol (1981) 0.81
Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res (2007) 0.81
Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut (1991) 0.81
Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas. Cytopathology (1999) 0.81
X-irradiation effects on thymidine kinase (TK): I. TK1 and 2 in normal and malignant cells. Cell Prolif (2002) 0.81
Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res (1992) 0.81
Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells. Biochim Biophys Acta (1983) 0.81
Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation. J Urol (1990) 0.81
Cell cycle distribution of proliferative and functional cells of the rat jejunum after treatment with oral E2 prostaglandins. Scand J Gastroenterol (1987) 0.81
Evaluation of tumor heterogeneity of prostate carcinoma by flow- and image DNA cytometry and histopathological grading. Anal Cell Pathol (2000) 0.81
Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res (1991) 0.80
Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Urology (1998) 0.80
Lack of correlation between thymidine kinase activity and changes of DNA synthesis with tumour age: an in vivo study in Ehrlich ascites tumour. Cell Tissue Kinet (1990) 0.80
Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study. Anticancer Res (1991) 0.80
Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. J Urol (1990) 0.80
Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin. Cancer Res (1982) 0.80